---
title: "4502.JP (4502.JP) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/4502.JP/news.md"
symbol: "4502.JP"
name: "4502.JP"
parent: "https://longbridge.com/en/quote/4502.JP.md"
datetime: "2026-05-22T05:08:37.265Z"
locales:
  - [en](https://longbridge.com/en/quote/4502.JP/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/4502.JP/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/4502.JP/news.md)
---

# 4502.JP (4502.JP) — Related News

### [Jury Hits Takeda With $885 Million Antitrust Verdict](https://longbridge.com/en/news/286951697.md)
*2026-05-19T17:48:45.000Z*
> Takeda Pharmaceutical faces an $885 million jury verdict in an antitrust case related to its drug Amitiza. The jury foun

### [](https://longbridge.com/en/news/286836884.md)
*2026-05-19T01:25:07.000Z*
> Takeda Pharmaceutical Company: Currently evaluating the amount of provisions to be recognized in the group's revenue for

### [Attorneys at Hagens Berman Announce $474M Win in Amitiza Jury Trial Against Takeda](https://longbridge.com/en/news/286824687.md)
*2026-05-18T22:15:22.000Z*
> Attorneys at Hagens Berman announced a $474.89 million jury verdict against Takeda Pharmaceuticals in a class-action law

### [Takeda Pharmaceutical Company Limited Just Recorded A 8.6% EPS Beat: Here's What Analysts Are Forecasting Next](https://longbridge.com/en/news/286620989.md)
*2026-05-15T22:09:57.000Z*
> Takeda Pharmaceutical Company Limited reported a statutory profit of JP¥122 per share, exceeding analyst expectations, w

### [Takeda Pharmaceutical Company large-scale layoffs](https://longbridge.com/en/news/286353215.md)
*2026-05-14T03:49:36.000Z*
> On May 13th, Takeda Pharmaceutical Company released its financial report, announcing plans to lay off approximately 4,50

### [Takeda Pharmaceutical Company Limited Stock 12‑Month Price Target Cut to $18.55, Implies 13% Upside](https://longbridge.com/en/news/286306439.md)
*2026-05-13T19:20:20.000Z*
> Takeda Pharmaceutical Company Limited's 12-month stock price target has been cut to $18.55, indicating a potential upsid